纳米材料在核医学中的应用

刘金剑; 刘鉴峰

doi:10.3760/cma.j.issn.1673-4114,2010.06.002

纳米材料在核医学中的应用

刘金剑 , 刘鉴峰

文章导航 > 国际放射医学核医学杂志 > 2010, 34 > 6: (326-329)

引用本文:

Citation:

纳米材料在核医学中的应用

中国医学科学院放射医学研究所实验核医学室, 天津市分子核医学重点实验室, 天津 300192
基金项目:
天津市自然科学基金(09JCYBJC13400)

国家自然科学基金(30700178)

The applications of nanomaterials in nuclear medicine

Tianjin Key Laboratory of Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China

摘要: 近年来随着纳米技术和纳米材料在医学应用中的迅速发展,尤其是在药物靶向传递和转基因载体等方面的不断深入研究,纳米材料也逐渐开始在核医学中应用。该文综述了目前几类纳米材料在核医学中的最新研究进展,并且讨论了其中存在的一些问题和今后发展的主要方向。
- 纳米医学 /
- 放射性核素显像
Abstract: Over the last decade, nanotechnology and nanomaterials have gained rapid development in medical application, especially in targeted drug delivery and gene transfer vector domain, and nano-materials are also beginning to applied in nuclear medicine. This paper is to make a view of the application research of several types of nanomaterials in nuclear medicine, and discusse some problems and the main direction of future development.
- Nanomedicine /
- Radionuclide imaging
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Intra J, Salem AK. Fabrication, characterization and in vitro evaluation of poly (D,L-lactide-co-glycolide) micmparticles loaded with polyamidoamine-plasmid DNA dendriplexes for applications in nonviral gene delivery. J Pharm Sci, 2010, 99(1):368-384.
[2]	Koning GA, Krijger GC. Targeted multifunetional lipid-based nanocarriers for image-guided drug delivery. Anticancer Agents Med Chem, 2007, 7(4):425-440.
[3]	Sawant RR, Torchilin VP. Polymeric micelles:polyethylene glycolphosphatidylethanolamine(PEG-PE)-based micelles as an example. Methods Mol Biol, 2010, 624:131-149.
[4]	Press OW, Rasey J. Principles of radioimmunotherapy for hematologists and oncologists. Semin Oncol, 2000, 27(6 Supp112):62-73.
[5]	Burke JM, Jurcic JG, Scheinberg DA. Radioimmunotherapy for acute leukemia. Cancer Control, 2002, 9(2):106-113.
[6]	Mulford DA, Scheinberg DA, Jurcic JG. The promise of targeted (alpha)-particle therapy. J Nucl Med, 2005, 46(Suppl 1):199S-204S.
[7]	Lin A, Chen J, Liu Y, et al. Preparation and evaluation of Neaproyl ehitosan nanopartieles surface modified with glyeyrrhizin for hepatoeyte targeting. Drug Dev Ind Pharm, 2009,35(11):13481355.
[8]	Li KC, Gueeione S, Bednarski MD. Combined vascular targeted imaging and therapy:a paradigm for personalized treatment. J Cell Biochem Suppl. 2002,39:65-71.
[9]	Häfeli UO, Sweeney SM, Beresford BA, et al. Magnetically directed poly (lactic acid) ⁹⁰Y-micmspheres:novel agents for targeted intracavitary radiotherapy. J Biomed Mater Res, 1994,28(8):901-908.
[10]	Chunfu Z, Jinquan C, Duanzhi Y, et al. Preparation and radiolabeling of human serum albumin (HSA)-coated magnetite nanoparticles for magnetically targeted therapy. Appl Radiat Isot, 2004, 61(6):1255-1259.
[11]	Kobayashi H, Sato N, Saga T, et al. Monoclonal antibody-dendrimer conjugates enable radiolabeling of antibody with markedly high specific activity with minimal loss of immuno-reactivity. Eur J Nucl Med, 2000, 27(9):1534-1339.
[12]	Sato N, Kobayashi H, Saga T, et al. Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice. Clin Cancer Res, 2001, 7(11):3606-3612.
[13]	Presant CA, Blayney D, Proffitt RT, et al. Preliminary report:imaging of Kaposi sarcoma and lymphoma in AIDS with indium-111-labelled liposomes. Lancet, 1990,335(8701):1307-1309.
[14]	Harrington K J, Rowlinson-Busza G, Syrigos KN, et al. Biodistribution and phatanaeokinetics of Hqn-DTPA-labelled pegylated liposomes in a human tumonr xenograft model:implications for novel targeting strategies. Br J Cancer,2000, 83(2):232-238.
[15]	Bao A, Coins B, Klipper R, et al. A novel liposome radiolabelingmethod using ⁹⁹Tc-"SNS/S" complexes:in vitro and in vivo evaluation. J Pharm Sci,2003,92(9):1893-1904.
[16]	Goldenberg DM. Targeted therapy of cancer with radiolabeled antibodies. J Nucl Med, 2002,43(5):693-713.
[17]	Chen X, Park R, Shahinian AH, et al. Pharmacokinetics and tumor retention of ¹²⁵I-labeled RGD peptide are improved by PEGylation. Nucl Med Biol,2004,31(1):11-19.
[18]	Line BR,Mitra A,Nan A, et al. Targeting tumor angiogenesis:comparison of peptide and polymer-peptide conjugates. J Nucl Med, 2005, 46(9):1552-1560.
[19]	Torchilin VP. Polymeric contrast agents for medical imaging. Curt Pharm Biotechnol, 2000, 1(2):183-215.
[20]	Torehilin VP,Lukyanov AN,Gao Z,et al. Immunomicelles:targeted pharmaceutical carriers for poorly soluble drugs. Proc Natl Acad Sci USA, 2003,100(10):6039-6044.

[1]	刘金剑 , 刘鉴峰 . 纳米材料在核医学中的应用. 国际放射医学核医学杂志, 2010, 34(6): 326-329. doi: 10.3760/cma.j.issn.1673-4114.2010.06.002
[2]	陈娜 , 涂彧 , 张旭光 . 纳米粒子在协同光动力放射治疗中的作用. 国际放射医学核医学杂志, 2010, 34(5): 318-320. doi: 10.3760/cma.j.issn.1673-4114.2010.05.018
[3]	唐宇辉 , 陈跃 . 纳米材料在多模式显像探针中的应用. 国际放射医学核医学杂志, 2011, 35(6): 325-329. doi: 10.3760,cma.j.issn.1673-4114.2011.06.002
[4]	唐宇辉 , 陈跃 . 纳米材料在多模式显像探针中的应用. 国际放射医学核医学杂志, 2011, 35(6): 325-329. doi: 10.3760/cma.j.issn.1673-4114.2011.06.002
[5]	乔鹏鑫 , 兰晓莉 , 王宽垠 , 覃春霞 . 放射性核素标记的金纳米颗粒在肿瘤诊疗中的研究进展. 国际放射医学核医学杂志, 2021, 45(6): 383-390. doi: 10.3760/cma.j.cn121381-202006007-00051
[6]	范永增 , 袁耿彪 . 靶向性纳米药物对肿瘤的应用研究. 国际放射医学核医学杂志, 2010, 34(1): 16-19. doi: 10.3760/cma.j.issn.1673-4114.2010.01.004
[7]	于建芳 . 核医学显像评估生殖与性功能障碍. 国际放射医学核医学杂志, 2002, 26(4): 169-172.
[8]	赵春雷 , 栗维国 , 罗锡圭 , 李亚明 . 核医学炎症显像对临床炎症性疾病的评价. 国际放射医学核医学杂志, 1996, 20(6): 250-254.
[9]	汪秀玲 , 侯先存 , 徐凯 . 核医学显像在乳腺癌诊疗中的作用. 国际放射医学核医学杂志, 2006, 30(4): 222-224.
[10]	王观筠 , 陈佳欣 , 王涛 , 徐白萱 . 核医学显像在肿瘤心脏病学中的研究进展. 国际放射医学核医学杂志, 2022, 46(10): 613-618. doi: 10.3760/cma.j.cn121381-202201010-00240